Seven Bridges

Seven Bridges is a biomedical data analysis and bioinformatics software company focused on cloud-based genomics, multi-omics, and clinical data analysis for research and precision medicine. The company built the Seven Bridges Platform and related products such as ARIA, GRAF, and RHEO to support large-scale workflow execution, data harmonization, and collaborative analysis across public and private datasets. Its customers have included biopharma companies, government agencies, healthcare organizations, and academic researchers, with notable work supporting programs such as the Cancer Genomics Cloud and other national-scale genomics initiatives. In January 2023, Seven Bridges was acquired by Summa Equity and combined with Pierian and UgenTec to form Velsera, where Seven Bridges continues as a product line and business unit within the broader precision medicine platform company.